Acarix (OTC:ACIXF) Stock, Quote.Headers.trade-ideas

Acarix AB is a Swedish medical technology company that develops solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics.

Acarix AB

Small Cap

Press Releases

Acarix Shares Begin Trading on the US-based OTCQB Market

Acarix announces shares are now being traded on the OTCQB under the ticker ACIXF

Earnings

Acarix AB (publ) publishes Interim Report, April - June 2024

Acarix Expands U.S. Reimbursement Coverage for CADScor System for use in Emergency and Outpatient Settings

Acarix Partners with Geo-Med to Extend the Availability of the CADScor System for Veterans

Acarix Publishes Year-End Report 2024

Acarix Named 2025 Digital Innovation Winner by Global Cardiovascular Awards

ACIXF

Acarix

Comments

Acarix

Acarix (OTC:ACIXF) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell